The rare entities/associations described, namely, atypical pituitary blastomas and pediatric cerebellar high-grade glioma with TP53 mutations, highlight the challenges of diagnosing CNS tumors via conventional pipelines [13]. Here, TP53 is linked to central nervous system cancer.